Search Results 2631-2640 of 25615 for oral

  1. A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet - Mayo Clinic

    ... oral or intravenous (IV) corticosteroids within 30 days of the first dose, or high-dose inhaled corticosteroids (>960 micrograms per day [μg/day] of ...

  2. A Study to Evaluate the Effectiveness, Safety and Tolerability of Efgatigimod PH20 SC in Adults with Pemphigus - Mayo Clinic

    receiving a tapered dose of oral prednisone (or the equivalent), provided that prednisone has been given at stable dose ± a conventional immunosuppressant ...

  3. Publications - Benjamin L. Wright, M.D. - Mayo Clinic

    Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy. Front Immunol. 2018; 9:2624 Epub 2018 Nov ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  5. Fibroadenoma - Diagnosis and treatment - Mayo Clinic

    Learn about this common breast lump. It is not cancer. Unless you have symptoms that bother you, treatment might not be needed.

  6. Desoximetasone (topical application route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Ointment; Cream; Gel/Jelly; Spray.

  7. Ryan T. Demmer, Ph.D., M.P.H. - Mayo Clinic Faculty Profiles

    This study is the Oral Infections Glucose Intolerance and Insulin Resistance Study (ORIGINS). The scientific aims of ORIGINS are to study the interplay ...

  8. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

    Patients with active, moderate-high disease activity RA (CDAI ≥ 10 and HAQ ≥ 0.5) despite the use of MTX ≥ 3 months with a stable dose ≥ 15 mg/week (oral or ...

  9. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

    Treatment with >1 IV dose of cyclophosphamide and/or >14 days of oral cyclophosphamide and/or >14 days of prednisone/prednisolone (>30 mg/day) and/or >1 ...

  10. A Study to Evaluate the Effectiveness and Safety of Apraglutide in Adults with Short Bowel Syndrome and Intestinal Failure - Mayo Clinic

    ... (oral, intravaginal, transdermal); progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); ...